The production of succinate with more CO 2 fixation reactions facilitated by RuBisCO ‐based engineered Escherichia coli
Biotechnology Progress · 2025
DOI: 10.1002/btpr.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2025. Verfasst von Xiuyuan Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Medicine, Shandong University of Technology, Zibo, China. Hauptthemen laut MEDLINE: Escherichia coli, Succinic Acid, Carbon Dioxide, Ribulose-Bisphosphate Carboxylase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Redesigning metabolic pathways to enhance the efficiency of carbon fixation during chemical biosynthesis is a promising approach for achieving cleaner and greener production of multi‐carbon compounds. In this study, we established a model of cell growth in Escherichia coli that is dependent on the RuBisCO‐Prk pathway by regulating its central metabolism. This rewiring ensures that growth depends on RuBisCO's carboxylation, allowing heterotrophic growth to rely on carbon fixation. This model was verified by detecting the growth curve, and it was used to screen four RuBisCO genes, of which the gene from Rhodospirillum rubrum ATCC 11170 serves as a growth advantage for E.coli . In addition, this model was applied to construct an efficient succinate biosynthetic pathway that can produce two moles of succinate from one mole of xylose and three moles of CO 2 . Compared to conventional succinate biosynthesis, this strategy has a CO 2 fixation capacity that is 1.5 times greater. Furthermore, to optimize succinate production, various approaches were employed, including the optimization of key enzymes, substrate transport, and the supply of inorganic carbon. The resulting strain was capable of producing succinate at a level of 2.09 ± 0.14 g/L, which is nearly 22.4 times that of the original strain. In conclusion, this study was developed for the production of two moles of succinate by implementing three moles of carbon fixation reactions and demonstrated the feasibility of various optimization strategies in biological carbon fixation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Medicine, Shandong University of Technology, Zibo, China.
- International Joint Laboratory on Extremophilic Bacteria and Biological Synthesis, Shandong University of Technology, Zibo, China.
ORCID-Profile: Xiutao Liu
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhou, X., Li, L., Sun, S., Xiong, P., & Liu, X. (2025). The production of succinate with more CO 2 fixation reactions facilitated by RuBisCO ‐based engineered Escherichia coli. Biotechnology Progress. https://doi.org/10.1002/btpr.70015
Vancouver
Zhou X, Li L, Sun S, Xiong P, Liu X. The production of succinate with more CO 2 fixation reactions facilitated by RuBisCO ‐based engineered Escherichia coli. Biotechnology Progress. 2025. doi:10.1002/btpr.70015
BibTeX
@article{Zhou2025,
author = {Zhou, Xiuyuan and Li, Linqing and Sun, Shengjie and Xiong, Peng and Liu, Xiutao},
title = {The production of succinate with more CO 2 fixation reactions facilitated by RuBisCO ‐based engineered Escherichia coli},
journal = {Biotechnology Progress},
year = {2025},
doi = {10.1002/btpr.70015}
}
EUVIMED